Busan is good

Busan Metropolitan City to Host the “2025 BIG (Busan is Good) Biohealth Forum”

내용

Busan Metropolitan City (Mayor Park Heong-joon) announced that it will host the “2025 BIG (Busan is Good) Biohealth Forum” today (July 7) at 2 PM at the Grand Ballroom of Asti Hotel Busan.

The forum is organized by Busan Metropolitan City and co-hosted by Busan Technopark (President Kim Hyung-gyun) and the Regional Medical Innovation Center of Seoul National University College of Medicine (Director Kang Dae-hee, Professor of Preventive Medicine, Seoul National University College of Medicine and Policy Advisor for Busan’s Biohealth Sector).

This year marks the second edition of the forum following its inaugural event last year. Around 100 attendees are expected, including hospital directors, officials from relevant institutions, biohealth experts, and corporate representatives. The event will feature a keynote address, expert presentations focused on strategies for a cancer-specialized city, and a panel discussion.

The keynote address, titled “Toward a Cancer-Specialized City, Busan!”, will be delivered by Kang Dae-hee, Policy Advisor for Biohealth to Busan. It will be followed by three themed sessions:
• Part 1: “Specialized City Busan Utilizing Digital Technology”
• Part 2: “Transforming the Korea Institute of Radiological & Medical Sciences, Dongnam Branch into an Asian Cancer Hub”
• Part 3: “Busan as a Hospital-Centered Cancer-Specialized City”

Expert presentations include:
• Han Min-kyu, Executive Director at Kakao Healthcare, on “Healthcare Services for Cancer Survivors”
• Choi Doo-ah, CEO of Huraypositive, on “Cloud-based Clinical Decision Support System (CDSS) and Cancer Patient Management Service for Precision Oncology”
• Lee Chang-hoon, President of the Korea Institute of Radiological & Medical Sciences, Dongnam Branch, on “Medical Use of Radiation and Establishment of a Cancer Treatment Hub”
• Ji Dae-yoon, CEO of FutureChem, on “Overcoming Cancer through Radiopharmaceutical Therapy”
• Cho Hong-jae, Director of Busan Regional Cancer Center, on “Current State of the Cancer Ecosystem in Busan”
• Han Won-shik, Director of the Breast Cancer Center at Seoul National University Hospital, on “Precision Medicine for Breast Cancer”
• Nam Ki-yeon, CEO of Qurient, on “Development of Targeted Therapeutics for Breast Cancer”

Following these, a panel discussion will be held under the theme “Strategies to Foster Busan’s Cancer Full-Cycle Healthcare Industry,” moderated by Policy Advisor Kang Dae-hee. Panelists include:
• Cho Hong-jae, Director, Busan Regional Cancer Center
• Nam Ki-yeon, CEO, Qurient
• Lee Chang-hoon, President, Korea Institute of Radiological & Medical Sciences, Dongnam Branch
• Ji Dae-yoon, CEO, FutureChem
• Shin Jae-guk, CEO of SPMed and Professor of Pharmacology, Inje University College of Medicine
• Han Min-kyu, Executive Director, Kakao Healthcare

Busan Metropolitan City plans to use this forum as a launching point to gather the innovative capacities of industry, academia, research, and medical sectors to formulate strategies for building a cancer-specialized city. The city will also establish an operational consultative body and working committees to develop and implement detailed action plans.

Deputy Mayor for Administrative Affairs Lee Jun-seung stated, “As the global trend of rapid aging continues, cancer incidence and mortality rates are also rising. Through this forum, we aim to thoroughly discuss the establishment of a full-cycle cancer healthcare ecosystem, encompassing prevention, early diagnosis, precision treatment, and survivor care.” He added, “We will build a strong cancer-specialized city brand centered on future-oriented cancer treatment infrastructure such as radiotherapy, heavy ion accelerator therapy, and advanced regenerative medicine.”